-
Bank Ranking
Banks Ratios
Cement Statistics
Cement Ranking
Cement Ratios
Monetary and Economic Statistics
Oil, Gas and Fuel
Macro Economy
Consumer Spending
Inflation
Exports & Imports
Food Prices
Non Food Prices
Construction Materials
Petrochem. Ranking
Petrochem. Ratios
Retail Rankings
Retail Ratios
Grocery Ranking
Grocery Ratios
Top Growth
Dividend History
Saudi German’s net profit drops 17% in 2017
26/03/2018
Argaam Exclusive
AI Summary
Content Summary: 
Loading data...
Please note that this news summary has been generated using artificial intelligence. It is recommended to review the original
sources for complete details and to verify the accuracy of the information.
Middle East Healthcare Co.’s (Saudi German Hospital) FY 2017 net profit fell 17 percent year-on-year (YoY) to SAR 300 million mainly due to the operation costs of newly-launched Hail hospital. There were also some increases in the salaries of caregivers, general and administrative expenses, and zakat, the company said in a statement to Tadawul.
Financials (M)
| Item | 2016 | 2017 | Change |
|---|---|---|---|
| Revenues | 1,615.64 | 1,462.39 | (9.5 %) |
| Gross Income | 828.39 | 597.87 | (27.8 %) |
| Operating Income | 358.37 | 294.77 | (17.7 %) |
| Net Income | 362.64 | 319.49 | (11.9 %) |
| Average Shares | 92.04 | 92.04 | - |
| Earnings Per Share before unusual items (Riyals) | 3.94 | 3.47 | (11.9 %) |
| EPS (Riyal) | 3.94 | 3.47 | (11.9 %) |
Current Quarter Comparison (M)
| Item | Q4 2016 | Q4 2017 | Change |
|---|---|---|---|
| Revenues | 404.96 | 364.60 | (10.0 %) |
| Gross Income | 199.88 | 145.47 | (27.2 %) |
| Operating Income | 87.04 | 73.06 | (16.1 %) |
| Net Income | 84.73 | 82.69 | (2.4 %) |
| Average Shares | 92.04 | 92.04 | - |
| Earnings Per Share before unusual items (Riyal) | 0.92 | 0.90 | (2.4 %) |
| EPS (Riyal) | 0.92 | 0.90 | (2.4 %) |
View other reports
Share Price
Middle East Healthcare Co. (SAUDI GERMAN HEALTH)
| Current | |
| Market Cap (M Riyal) | 5,347.53 |
| Enterprise Value (EV) (M Riyal) | 7,698.25 |
| Shares Outstanding ((M)) | 92.04 |
| EPS ( Riyal) (TTM) | 4.27 |
| Book Value (BV) ( Riyal) | 19.60 |
| Par Value ( Riyal) | 10.00 |
| Recurring P/E | 22.93 |
| P/E (TTM) | 13.62 |
| Price/book | 2.96 |
| Return on Average Assets (%) (TTM) | 7.4 |
| Return on Average Equity (%) (TTM) | 24.3 |
| EV/adj EBITDA | 11.64 |
| EV/Revenues | 2.56 |
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2017 | 393.53 | (6.6 %) | 180.47 | (16.7 %) | 107.04 | 3.2 % |
| Q2 2017 | 351.28 | (14.3 %) | 138.63 | (34.8 %) | 58.97 | (23.0 %) |
| Q3 2017 | 352.98 | (6.9 %) | 133.30 | (33.1 %) | 55.70 | (38.9 %) |
| Q4 2017 | 364.60 | (10.0 %) | 145.47 | (27.2 %) | 73.06 | (16.1 %) |
| 2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 294.77 | (17.7 %) |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS(Riyal) |
|---|---|---|---|---|---|---|
| Q1 2017 | 109.97 | 5.5 % | 1.19 | - | 109.97 | 1.19 |
| Q2 2017 | 61.95 | (16.4 %) | 0.67 | - | 61.95 | 0.67 |
| Q3 2017 | 64.88 | (34.9 %) | 0.70 | - | 64.88 | 0.70 |
| Q4 2017 | 82.69 | (2.4 %) | 0.90 | - | 82.69 | 0.90 |
| 2017 | 319.49 | (11.9 %) | 3.47 | - | 319.49 | 3.47 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2016 | 52.27 % | 27.77 % | 24.87 % |
| Q2 2016 | 51.57 % | 26.50 % | 23.17 % |
| Q3 2016 | 51.71 % | 26.41 % | 23.34 % |
| Q4 2016 | 51.27 % | 26.12 % | 22.45 % |
| 2016 | 51.27 % | 26.12 % | 22.45 % |
| Q1 2017 | 49.90 % | 26.91 % | 23.20 % |
| Q2 2017 | 46.99 % | 27.02 % | 23.30 % |
| Q3 2017 | 43.41 % | 25.39 % | 21.40 % |
| Q4 2017 | 40.88 % | 25.40 % | 21.85 % |
| 2017 | 40.88 % | 25.40 % | 21.85 % |
Compared With The
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Earnings Per Share before unusual items (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2017 | 92.04 | 4.00 | 4.00 | 18.46 |
| Q2 2017 | 92.04 | 3.87 | 3.87 | 17.09 |
| Q3 2017 | 92.04 | 3.49 | 3.49 | 17.74 |
| Q4 2017 | 92.04 | 3.47 | 3.47 | 15.75 |
Multiple Ratios (End of Period Price)
| Period | P/E | Recurring P/E | Price/book |
|---|---|---|---|
| Q1 2017 | 18.48 | 18.48 | 4.01 |
| Q2 2017 | 19.45 | 19.45 | 4.41 |
| Q3 2017 | 17.98 | 17.98 | 3.54 |
| Q4 2017 | 15.52 | 15.52 | 3.42 |
Business Segments (Million)
Q4 2017
| Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
|---|---|---|---|---|
| Q1 2017 | 242.80 | 104.89 | 71.94 | 4.27 |
| Q2 2017 | 224.48 | 92.89 | 70.77 | 3.54 |
| Q3 2017 | 133.39 | 85.39 | 60.16 | 3.27 |
| Q4 2017 | 172.44 | 114.51 | 71.35 | 6.30 |
Analysts Estimates (Million)
| Item | Profit (Expected) | Profit (Actual) | Change |
|---|---|---|---|
| Average | 66.24 | 82.69 |
Estimates vs Actual (Million)
| Item | Profit (Expected) | Profit (Actual) | Change |
|---|---|---|---|
| Arbah Capital | 74.40 | 82.69 | |
| AlJazira Capital | 70.50 | 82.69 | |
| SNB Capital | 64.00 | 82.69 | |
| Sico | 64.00 | 82.69 | |
| OSOOL AND BAKHEET | 58.30 | 82.69 |
Follow us on
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Call Request
Comments Analysis: